Możliwości dofinansowania venture capital - BioTech-IP

„Możliwości dofinansowania
venture capital –
doświadczenia Wielkiej Brytanii”
Warszawa 2013
Copyright © i-Tech Innovations Ltd 2011
www.itechinnovations.co.uk
Pawel Zolnierczyk MPhys, MEnT(Hons)
Technology Transfer Professional
Onco-NX Limited, UK – Managing Director
University of Salford, UK – Intellectual Property Manager
Copyright © i-Tech Innovations Ltd 2011
www.itechinnovations.co.uk
Copyright © i-Tech Innovations Ltd 2011
www.itechinnovations.co.uk
Alternatywne źródła finansowania badań
Source
Stage, focus
Charities
Research, disease,
Gov-related Charitable org
Close to application,
collaboration with industry
VC like charities
Well defined Application
Seed funds ‘risk relaxed’
Spin-off, ROI driven,
SEIS
SME, TAX - relief
Business Angels
SME, ROI driven
VC
SME, ROI driven
Copyright © i-Tech Innovations Ltd 2011
www.itechinnovations.co.uk
Charities
Gov-related org
Biomedical Catalyst
The £180 million Biomedical Catalyst is an integrated
translational funding programme jointly operated by the
Medical Research Council and the Technology
Strategy Board providing responsive and effective
support for the best life science opportunities arising in
the UK.
Support through the Biomedical Catalyst is available to
UK businesses (SMEs) and academics looking to
develop innovative solutions to healthcare challenges
either individually or in collaboration.
Large charities – VC alike
Seed funds
SEIS
Business Angels
Venture Capitals
Dziękuję za uwagę